EVP, Chief Commercial Officer · Jazz Pharmaceuticals plc · Jazz Pharmaceuticals plc — Non-Qualified Stock Option (right to buy)
Side
M
Value
—
Shares
6,907
Price
—
Executed
May 28, 2026
Disclosed
Jun 1, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
May 28 executedJun 1, 2026 disclosed
JAZZ · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Jazz Pharmaceuticals plc — Non-Qualified Stock Option (right to buy)
Ticker
JAZZ
Shares
6,907
Price per share
$0
Execution date (reported)
May 28, 2026
Owned after transaction
0 shares
Days from execution to publication
4
What this establishes
Pearce Samantha filed this Form 4 reporting a option exercise of JAZZ on May 28, 2026. It became public on Jun 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP, Chief Commercial Officer
Pearce Samanthacik:0001805688
Issuer
Jazz Pharmaceuticals plccik:0001232524
Revision history · 0
No field has changed since this record was first ingested.
